- €155.90bn
- €202.32bn
- $62.58bn
Medicus Pharma surges on Pfizer licensing deal for experimental cancer therapy
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Factbox: Global pharma companies that have publicly announced Trump drug pricing agreements
Trump administration announces drug pricing deals with CSL, Astellas and others (updated)
Trump administration to announce drug pricing deals
Roivant, Priovant launch newly approved rare disease drug Lisraya at $35,000 a month (updated)
Alnylam, Ionis fall as heart-drug data raise doubts over combination treatment
US FDA approves updated COVID vaccines for 2026-27 season
China's drug regulator accepts Novo Nordisk's application for oral Wegovy (updated)
Focus: Snoring, subways and stealth ads: how big pharma targets China's waistline
Arbutus climbs after unveiling buyback from Moderna settlement proceeds
Factbox: Pharma sector doubles down on AI amid hopes of slashing costs, timelines
Biotech stocks hit record high after Moderna, Merck's melanoma vaccine trial win
Biotech stocks jump after Moderna, Merck's melanoma vaccine succeeds in large trial
GE HealthCare appoints William Grogan as CFO, replacing Jay Saccaro
Valneva surges after EU regulator validates Lyme disease vaccine application
Brief: Pfizer And Valneva's Lyme Disease Vaccine Candidate Marketing Authorization Application Validated By European Medicines Agency
Valneva falls after H1 revenue, operating profit drop
Factbox: Global drugmakers invest billions to boost US presence